Method and product for the sequence determination of peptides using a mass spectrometer
US6271037B1 · Rockefeller University · priority 1992
Patent US6271037B1 (Rockefeller University, Expired - Lifetime): Method is described for sequencing polypeptides by forming peptide ladders comprising a series of polypeptides in which adjacent members of the series vary by one amino acid residue…
| Patent | US6271037B1 ↗ |
| Status | Expired - Lifetime |
| Priority date | 1992-05-29 |
| Filed | 1993-05-27 |
| Published (granted) | 2001-08-07 |
| Assignee | Rockefeller University (printed Rockefeller University; Scripps Research Institute) |
| Also published as | ATE427493T1, AU4395893A, AU685055B2, CA2136717A1, DE69334274D1, EP0664884A1, EP0664884A4, EP1130399A2, EP1130399A3, EP1130399B1, JPH07507394A, US20030059952A1, US20040265944A1, US20050153454A1, US6750061B2, US7341874B2, WO1993024834A1 |
Abstract
Method is described for sequencing polypeptides by forming peptide ladders comprising a series of polypeptides in which adjacent members of the series vary by one amino acid residue and determining the identity and position of each amino acid in the polypeptide by mass spectroscopy.
Why it is here
Rockefeller University (Chait): protein ladder sequencing, residues read from the mass differences between adjacent ladder members.
Inventors (4)
Brian T. Chait, Ronald Beavis, Rong Wang, Stephen B. H. Kent
An inventor links to an author page only where the same person is evident, never on a name alone.
Catalogued patents it cites (1)
- WO1994006017A1 Peptide sequencing using mass spectrometry
Cited by catalogued patents (1)
- US6829539B2 Methods for quantification and de novo polypeptide sequencing by mass spectrometry
Cited by (89 patent families, 40 organisations)
- Syn X Pharma company: US6593298B2, US6599877B2, US6602855B2, US6617308B2, US6620786B2, US6620787B2, US6627606B2, US6627607B2, US6677303B2, US6693080B2, US6756476B2, US6890763B2, US7049397B2, US7087435B2, US7132244B2, US6890722B2, US7015004B2, US7026129B2, US7052849B2, US7074576B2, US7094549B2, US7097989B2, US7179606B2
- Nanogen company: US7294688B2, US7314717B2, US7314762B2, US7122327B2, US7125678B2, US7135297B2, US7179605B2, US7179610B2
- Massachusetts Institute of Technology academic: EP4032538A3, EP3440013A4, WO2017193070A1, AU2018248327B2, EP3856921B1, EP3911753A1
- Applera company: US20050147985A1, US20050148087A1, US7307169B2, US7355045B2
- Knopp Biosciences company: US9662313B2, US9468630B2, EP3033081B1, ES2813674T3
- George Jackowski company: US20020160533A1, US20040198950A1, US6703366B2
- Sequenom company: CA2270132A1, US6207370B1, US7785843B2
- Abbott Molecular company: EP3147665A1, US9347945B2
- Banyan Biomarkers company: EP3336551B1, US12601749B2
- Shimadzu Res Lab Europe company: GB0212470D0, GB0503411D0
- Univ Florida company: EP1745149A4, ES2732071T3
- University of Florida Research Foundation academic: WO2006047417A2, US8048638B2
- Areteia Therapeutics company: RS67279B1
- Artemis Proteomics company: US7008800B2
- Biogen Idec Ma company: WO2013096816A1
- Caesar Stiftung company: DE10036342C2
- Charles River Laboratories International company: US12135330B2
- Ciphergen Biosystems company: NZ516848A
- Compugen company: IL138946A0
- Eastern Virginia Medical School academic: WO2006074360A2
- Genetics Inst company: ATE405839T1
- Genetics Institute academic: EP1330654B1
- Genetrace Systems company: CA2274587A1
- Institute for Systems Biology academic: US6829539B2
- Knopp Neurosciences company: US8519148B2
- Life Technologies company: EP1588145B1
- Massachusetts Inst Technology company: ES2881535T3
- Mds Proteomics company: EP1409714A4
- Perseptive Biosystems company: US5827659A
- Sri International company: US5830655A
- University of Pittsburgh of the Commonwealth System of Higher Education academic: WO2005042761A2
- University of Pittsburgh-Of the Commonwealth System of Higher Education academic: WO2006071469A2
- University of Virginia Patent Foundation academic: US20080319678A1
- アジレント・テクノロジーズ・インク company: JP7315564B2
- ノップ ニューロサイエンシーズ、インク. company: JP2012500283A
- ノバルティス アクチエンゲゼルシャフト company: JP2009515542A
- バンヤン・バイオマーカーズ・インコーポレイテッド company: JP6063378B2
- バンヤン・バイオマーカーズ・インコーポレーテッド company: JP2020500508A
- マサチューセッツ インスティテュート オブ テクノロジー company: JP6847660B2
- 普隆奈治疗公司 company: CN104884637A
Every family, of any applicant, that cites this one, as Google Patents lists them; an assignee is given its English name.